$235 Million is the total value of PURA VIDA INVESTMENTS, LLC's 74 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDT | New | MEDTRONIC PLC | $6,942,000 | – | 80,000 | +100.0% | 2.95% | – |
| BDX | New | BECTON DICKINSON & COput | $6,360,000 | – | 37,500 | +100.0% | 2.70% | – |
| SYK | New | STRYKER CORP | $4,793,000 | – | 40,000 | +100.0% | 2.04% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INCput | $4,379,000 | – | 37,500 | +100.0% | 1.86% | – |
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $4,296,000 | – | 99,125 | +100.0% | 1.83% | – |
| CVS | New | CVS HEALTH CORP | $3,830,000 | – | 40,000 | +100.0% | 1.63% | – |
| CPHD | New | CEPHEID | $2,921,000 | – | 95,000 | +100.0% | 1.24% | – |
| CYNO | New | CYNOSURE INCcl a | $2,919,000 | – | 60,000 | +100.0% | 1.24% | – |
| XENT | New | INTERSECT ENT INC | $2,780,000 | – | 215,000 | +100.0% | 1.18% | – |
| CSII | New | CARDIOVASCULAR SYS INC DEL | $2,670,000 | – | 145,289 | +100.0% | 1.14% | – |
| HRC | New | HILL ROM HLDGS INC | $2,270,000 | – | 45,000 | +100.0% | 0.96% | – |
| VAR | New | VARIAN MED SYS INCput | $2,056,000 | – | 25,000 | +100.0% | 0.87% | – |
| AVXS | New | AVEXIS INC | $1,931,000 | – | 50,800 | +100.0% | 0.82% | – |
| GWPH | New | GW PHARMACEUTICALS PLCcall | $1,648,000 | – | 18,000 | +100.0% | 0.70% | – |
| VIVE | New | VIVEVE MED INC | $1,513,000 | – | 368,919 | +100.0% | 0.64% | – |
| NUVA | New | NUVASIVE INC | $1,493,000 | – | 25,000 | +100.0% | 0.64% | – |
| XENT | New | INTERSECT ENT INCcall | $1,293,000 | – | 100,000 | +100.0% | 0.55% | – |
| OPHT | New | OPHTHOTECH CORPcall | $1,276,000 | – | 25,000 | +100.0% | 0.54% | – |
| New | NEURODERM LTD | $401,000 | – | 24,683 | +100.0% | 0.17% | – | |
| ADMA | New | ADMA BIOLOGICS INC | $217,000 | – | 36,500 | +100.0% | 0.09% | – |
| New | NEOVASC INC | $135,000 | – | 262,060 | +100.0% | 0.06% | – | |
| STDY | New | STEADYMED LTD | $94,000 | – | 28,758 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.